Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Jumpcode Genomics Launches CRISPRclean Single Cell RNA Boost Kit

    Apr 7, 2022, 17:59 PM by
    CRISPRclean® technology improves single cell transcriptional profiling, enabling scientists to discover and see signals that were previously obscured by abundant genomic sequences
    Full story
  • Analytical News: T,C&A Lab Offers Insights on Carbon Fiber Testing

    Apr 7, 2022, 17:59 PM by
    Alfa Chemistry’s testing branch - T,C&A Lab, has recently announced to provide carbon fiber testing service for customers worldwide. Experts from Alfa Chemistry will offer insights on a series of tests carried out to characterize carbon fiber performance.
    Full story
  • Samsung Biologics holds 11th Annual General Meeting of Shareholders

    Apr 7, 2022, 17:59 PM by
    Full story
  • CTL Amedica Corp Increases International Footprint: Receives Two Product Registration Certifications from Guatemala Ministry of Public Health and Social Assistance

    Apr 7, 2022, 17:59 PM by
    The Guatemala Ministry of Public Health and Social Assistance has certified CTL Amedica Corporation’s registration for two product lines: the VALEO™ II TL Silicon Nitride Interbody Fusion Devices, and the RAPHAEL™ Pedicle Fixation Platform. This certification will enable CTL Amedica to market these products in Guatemala. This is CTL Amedica’s first product registration certification in Central America, and the company says it will continue its efforts to make its technologies more accessible internationally.
    Full story
  • Creative Biogene Released One-Stop C. elegans Aging Research Services to Fuel Your Aging Studies

    Apr 7, 2022, 17:59 PM by
    Creative Biogene announced the release of one-stop C. elegans aging research services to accelerate the speed of partners’ aging studies.
    Full story
  • Stanley Capital-backed portfolio company DSS acquires MyMeds&Me

    Apr 7, 2022, 17:59 PM by
    Stanley Capital-backed portfolio company DSS acquires MyMeds&Me 04 April 2022, London - Stanley Capital Partners LLP (SCP), the European and US-focused mid-market private equity firm, today announced the acquisition of MyMeds&Me Limited (MMM) by its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS). DSS is a leading global provider of pharmacovigilance services under the brand Bioclinica. The financial terms of the transaction are not being disclosed.
    Full story
  • 13th Edition of International Conference on Catalysis, Chemical Engineering and Technology

    Apr 7, 2022, 17:59 PM by
    Content 1 Magnus Group is proud and honoured to invite you to its leading congress in catalysis and chemical engineering, “13th Edition of International Conference on Catalysis, Chemical Engineering and Technology” (Catalysis 2022) which is going to be held in a hybrid format at Orlando, Florida, USA and Virtually during October 21-22, 2022.
    Full story
  • PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification

    Apr 7, 2022, 17:59 PM by
    New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
    Full story
  • CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

    Apr 7, 2022, 17:59 PM by
    Full story
  • Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

    Apr 7, 2022, 17:59 PM by
    Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform
    Full story
  • COMPREHENSIVE OFFERING OF LIQUID STABLE BIO-SYNTHETIC REFERENCE MATERIALS FOR URINE CHEMISTRIES NOW AVAILABLE FROM VERICHEM

    Apr 7, 2022, 17:59 PM by
    VERICHEM now offers clinical laboratorians a comprehensive range of liquid stable and ready-to-use biosynthetic clinical reference materials designed for system calibration and calibration verification testing procedures with urine chemistry assays.
    Full story
  • CluePoints Continues Impressive Global Growth with Three New Senior Appointments

    Apr 7, 2022, 17:59 PM by
    CluePoints Continues Impressive Global Growth with Three New Senior Appointments The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team King of Prussia, PA – 5th April, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.
    Full story
  • WCG Unveils Strategic Alliance Program for CROs

    Apr 7, 2022, 17:59 PM by
    Leading CROs Increase Adoption of WCG's Suite of Solutions Enabling Connectivity to Top Clinical Trial Sites Via Unrivaled Technology and Staffing Solutions Global Program Drives Collaboration to Increase Efficiency and Reduce Burden on Investigative Sites, Accelerating Clinical Trials Sponsored by Pharmaceutical, Biotech and Medical Device Companies
    Full story
  • Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market

    Apr 7, 2022, 17:59 PM by
    Seasoned Healthcare Industry Executive Joins Organization to Lead Business Development, Acquisitions, and Expansion into New Markets
    Full story
  • Rho Hires Global VP of Quality Assurance to Support International Expansion following Acquisition

    Apr 7, 2022, 17:59 PM by
    Full story
  • Epic Selects Lyniate for Integration within the Epic Garden Plot Offering

    Apr 7, 2022, 17:59 PM by
    Full story
  • Novel drug from Neuro-Bio effective in a mouse model of Alzheimer's Disease

    Apr 7, 2022, 17:59 PM by
    Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease.
    Full story
  • PubHive Integrates Unpaywall Into PubHive Navigator

    Apr 7, 2022, 17:59 PM by
    Cloud software platform PubHive Navigator saves time for life science teams by expanding journal article access via the platform’s research literature workflow module Fetch
    Full story
  • Alfa Chemistry Refreshed Its Website for the Supply of MOF Chemicals

    Apr 7, 2022, 17:59 PM by
    Earlier this year, Alfa Chemistry, a well-established chemical supplier based in New York, announced its decision to further optimize its supply of MOF chemicals, a new material that has huge potentials in fields like gas storage, separation, and catalysis. Now the company has completed the website refresh work and introduced a new brand logo. All these efforts are made in the hope of bringing better customer experience and more convenient website searching.
    Full story
  • CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects

    Apr 7, 2022, 17:59 PM by
    Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.
    Full story
  • «
  • 141
  • 142
  • 143
  • 144
  • 145 (current)
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy